|
Volumn 9, Issue 1-2, 2003, Pages 167-171
|
Helicobacter pylori and rosacea
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
IMMUNOGLOBULIN G;
ADULT;
AGE;
AGED;
ANTIBODY TITER;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL EXAMINATION;
CONTROLLED STUDY;
CORRELATION ANALYSIS;
DISEASE ASSOCIATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
IRAN;
MALE;
PREVALENCE;
ROSACEA;
SAMPLE SIZE;
SEROLOGY;
SEX DIFFERENCE;
TREATMENT OUTCOME;
BLOOD;
CASE CONTROL STUDY;
CLASSIFICATION;
DISEASE COURSE;
EPIDEMIOLOGY;
GASTRITIS;
HEALTH SURVEY;
HOSPITALIZATION;
IMMUNOLOGY;
MICROBIOLOGY;
MIDDLE AGED;
ADULT;
AGED;
CASE-CONTROL STUDIES;
CAUSALITY;
DISEASE PROGRESSION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FEMALE;
GASTRITIS;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
IMMUNOGLOBULIN G;
IRAN;
MALE;
MIDDLE AGED;
POPULATION SURVEILLANCE;
ROSACEA;
SAMPLE SIZE;
SEROEPIDEMIOLOGIC STUDIES;
SEVERITY OF ILLNESS INDEX;
|
EID: 16544388000
PISSN: 10203397
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (24)
|
References (11)
|